Halmuthur.M.Sampath Kumar
Academy of Scientific and Innovative Research (AcSIR), Vaccine Immunology Laboratory Division of Natural Products Chemistry, Indian Institute of Chemical Technology, India

Biography

Halmuthur.M.Sampath Kumar, , obtained his MSc degree (Organic Chemistry) from Gulbarga University, India and PhD from CSIR- Indian Institute of Chemical Technology, Hyderabad(1995) in the area of biomimetic chemistry. He later moved to Max Planck Institute, Dortmund in the year 2000 to work as Humboldt Fellow with Prof. Waldmann in the area of gene therapy. After returning to India, he continued to work at CSIR-IICT in the area of agrochemical and pharmaceutical technology development. Subsequently he relocated to Regional Research Laboratory(2004)-Jammu, presently rechristened as CSIR-IIIM, where, he initiated major projects on vaccine adjuvants and cosmeceuticals. His team developed novel skin care hybrid molecules and worked on major collaboarative projects with P&G and Colgate Plamolive on oral and skin care product development. He served as the Chairman of the Synthetic and Biological Chemistry Department of CSIR-IIIM, Jammu till 2009. He is the nodal scientist for the vaccine immunology programme at CSIR-IICT, Hyderabad. Focus of his current research is on the development of novel small molecule immunomodulators, and vaccine(Th1) adjuvants. and peptide based synthetic vaccines for cancer and other diseases involving intracellular pathogenesis. His group is actively pursuing research in the ara of cosmeceuticals with a focus on the development of minimum cosmeceuticals employing hybrid technologies, herbal cosmeceutical products based on Ayurveda-the Indian traditional system of medicine

Research Interest

Discovery of novel Immunomodulators, Development of Novel Th1/Th2 adjuvants for subunit vaccines. peptide epitope based wholly synthetic vaccines, Cosmeceuticals: Perfumery Hybrid s, herbal cosmeceuticals, multiple action skin care products, Natural product scaffold modification for new lead discovery, Target based drug design. Structural modifications of natural products as a means of new lead discovery and synthesis of focused libraries of target interactive ligands based on natural products, Bio-conjugate chemistry/medicinal chemistry, Solid phase synthesis of carrier peptide-conjugates and their application in plant secondary metabolic engineering and gene therapy, Anticancer, anti-infective hybrid molecules, Development of cancer vaccines based on tumor associated glycopeptide antigens, Total synthesis of complex carbogenic molecules and development of new synthetic methods. Novel combinatorial methodologies.